Andere Sprachen Fortress Biotech, Inc. Nasdaq

Aktien

A2PYCP

US34960Q2084

FBIOP

Markt geschlossen - Nasdaq Andere Börsenplätze 21:59:12 14.06.2024			% 5 Tage	% 1. Jan.
16,68 ^USD	-0,71 %		-0,33 %	+40,48 %

15.05.	Fortress Biotech, Inc. meldet Ergebnis für das erste Quartal zum 31. März 2024	CI
14.05.	Fortress Biotech gibt bekannt, dass der erste Patient in der Phase-2-Studie von Triplex behandelt wurde	MT

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

Fortress Biotech to Participate in the Alliance Global Partners’ (A.G.P.) Virtual Healthcare Company Showcase	16.05.
Fortress Biotech: Q1 Earnings Snapshot	15.05.
Fortress Biotech, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	15.05.
Earnings Flash (FBIO) FORTRESS BIOTECH Posts Q1 Revenue $13M	15.05.
Fortress Biotech Reports First Quarter 2024 Financial Results and Recent Corporate Highlights	15.05.
Journey Medical Corporation to Participate in the Alliance Global Partners’ (A.G.P.) Virtual Healthcare Company Showcase	15.05.
Fortress Biotech Says First Patient Dosed in Phase 2 Study of Triplex	14.05.
Fortress Biotech Announces First Patient Dosed in Multi-Center Phase 2 Study of Triplex for Control of CMV in Patients Undergoing Liver Transplantation	14.05.
Fortress Biotech Announces First Patient Dosed in Multi-Center Phase 2 Study of Triplex for Control of CMV in Patients Undergoing Liver Transplantation	14.05.
Journey Medical Corporation Reports First Quarter 2024 Financial Results and Recent Corporate Highlights	13.05.
Journey Medical Corporation to Announce First Quarter 2024 Financial Results on May 13, 2024	07.05.
Journey Medical Corporation Appoints Joseph Benesch as Chief Financial Officer	01.05.
Avenue Therapeutics Announces Exercise of Warrants for $4.4 Million in Gross Proceeds	29.04.
Journey Medical Corporation to Present at the Planet MicroCap Showcase: Vegas 2024	25.04.
Avenue Therapeutics Announces Reverse Stock Split	24.04.
North American Morning Briefing : Powell Awaited -2-	03.04.
Certain Warrants of Fortress Biotech, Inc. are subject to a Lock-Up Agreement Ending on 2-APR-2024.	02.04.
Certain Options of Fortress Biotech, Inc. are subject to a Lock-Up Agreement Ending on 2-APR-2024.	02.04.
Certain Common Stock of Fortress Biotech, Inc. are subject to a Lock-Up Agreement Ending on 2-APR-2024.	02.04.
Fortress Biotech, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	28.03.

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Fortress Biotech, Inc. Nasdaq

Aktien

A2PYCP

US34960Q2084

FBIOP

Andere Sprachen

Filter